jcm-logo

Journal Browser

Journal Browser

Latest Advances on Urological Surgery

A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Nephrology & Urology".

Deadline for manuscript submissions: closed (20 November 2022) | Viewed by 16872

Special Issue Editor


E-Mail Website1 Website2
Guest Editor
1. Urology at Dept. of Medicine and Translational Surgery, Università Cattolica del Sacro Cuore, Largo Vito 1, 00168 Rome, RM, Italy
2. Functional Urology Unit at Urology Dept., Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Largo Agostino Gemelli 8, 00168 Rome, RM, Italy
Interests: urologic surgery; robotic surgery; reconstructive surgery; pelvic floor dysfunctions; urinary incontinence; bladder cancer; prostate cancer; urinary tract infections; kidney cancer
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Urology has always been at the forefront of surgical innovation. In the last decades, new technologies and surgical approaches were introduced that radically changed the management of several urological disorders, improving patient outcomes. Minimally invasive techniques led to substantial advances in terms of oncological and functional results, morbidity and quality of life. The laparoscopic frontier is steadily moving ahead, in terms of both engineering and surgical techniques. Urologists have been leaders in adopting robotic surgery, and astounding progress is ongoing in this field, with further potential for widespread penetration of this technology resulting from the recent introduction of newer robotic platforms. Further amazing advances can be envisaged with the introduction of the developing technologies of digital surgery. Progress is also occurring rapidly in the field of endoscopic surgery for BPH and urolithiasis. Alongside the most amazing technological developments, continuous refinements are under investigation in already consolidated surgical techniques and strategies. The importance of these innovations is even greater when considering that they improve the treatment of diseases that are very prevalent and increasingly frequent in Western countries, including prostate and bladder cancer, stone disease and lower urinary tract dysfunctions. However, there is an urgent need to provide new and more compelling proof of efficacy and cost-effectiveness of new surgical procedures compared with older approaches.

This Special Issue of the Journal of Clinical Medicine aims to publish contributions from distinguished authors who actively experience innovations in the field of urological surgery and want to provide more solid scientific evidence. All researchers are invited to contribute original works and reviews (animal research, case reports and short reviews are not accepted).

Prof. Dr. Emilio Sacco
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • minimally invasive procedures
  • robotic surgery
  • laparoscopy
  • digital surgery
  • reconstructive surgery
  • pelvic surgery
  • incontinence surgery
  • endoscopy
  • endourology
  • uroandrology
  • surgical training

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue polices can be found here.

Published Papers (8 papers)

Order results
Result details
Select all
Export citation of selected articles as:

Editorial

Jump to: Research, Other

3 pages, 174 KiB  
Editorial
Special Issue: “Latest Advances on Urological Surgery”
by Emilio Sacco
J. Clin. Med. 2023, 12(13), 4452; https://doi.org/10.3390/jcm12134452 - 3 Jul 2023
Cited by 1 | Viewed by 840
Abstract
Urology has always been at the forefront of surgical innovation which aims to improve patients outcomes and cost-effectiveness [...] Full article
(This article belongs to the Special Issue Latest Advances on Urological Surgery)

Research

Jump to: Editorial, Other

12 pages, 1256 KiB  
Article
Robotic versus Open Pyeloplasty: Perioperative and Functional Outcomes
by Stefano Moretto, Carlo Gandi, Riccardo Bientinesi, Angelo Totaro, Filippo Marino, Filippo Gavi, Andrea Russo, Paola Aceto, Francesco Pierconti, Pierfrancesco Bassi and Emilio Sacco
J. Clin. Med. 2023, 12(7), 2538; https://doi.org/10.3390/jcm12072538 - 28 Mar 2023
Cited by 10 | Viewed by 1695
Abstract
We designed a retrospective study to assess the surgical and economic outcomes of robot-assisted laparoscopic pyeloplasty (RALP) compared with open pyeloplasty (OP), including consecutive patients suffering from ureteropelvic junction obstruction and operated on from January 2012 to January 2022 at a single center. [...] Read more.
We designed a retrospective study to assess the surgical and economic outcomes of robot-assisted laparoscopic pyeloplasty (RALP) compared with open pyeloplasty (OP), including consecutive patients suffering from ureteropelvic junction obstruction and operated on from January 2012 to January 2022 at a single center. Preoperative, intraoperative, and postoperative outcomes, including costs, were comparatively analyzed. The primary outcome was 3-month success, defined as symptom resolution and no obstruction upon diuretic renal scintigraphy. Overall, 91 patients were included (48 OP and 43 RALP). The success rate at 3 months was 93.0% and 83.3% in the RALP and OP group, respectively (p = 0.178), and the results remained stable at the last follow-up (35.4 ± 22.8 months and 56.0 ± 28.1 months, respectively). Intraoperative blood loss (p < 0.001), need for postoperative analgesics (p = 0.019) and antibiotics (p = 0.004), and early postoperative complication rate (p = 0.009) were significantly lower in the RALP group. None of the assessed variables were a predictor for failure. The mean total direct cost per surgical procedure and related hospital stay was 2373 € higher in the RALP group. RALP is an effective and safe treatment for ureteropelvic junction obstruction; however, further studies are needed to evaluate the cost-effectiveness of RALP, accounting for indirect costs and cost-saving with new surgical platforms. Full article
(This article belongs to the Special Issue Latest Advances on Urological Surgery)
Show Figures

Figure 1

9 pages, 609 KiB  
Article
Ejaculation Sparing Thulium Laser Enucleation of the Prostate: An Observational Prospective Study
by Francesco Trama, Giovanni Di Lauro, Ester Illiano, Fabrizio Iacono, Leo Romis, Salvatore Mordente, Maria Rosaria Nugnes, Stefano Lai, Felice Crocetto, Biagio Barone, Francesco Paolo Calace, Giuseppe Romeo and Elisabetta Costantini
J. Clin. Med. 2022, 11(21), 6365; https://doi.org/10.3390/jcm11216365 - 28 Oct 2022
Cited by 14 | Viewed by 2052
Abstract
Benign prostatic hypertrophy (BPH) is a condition that appears with advancing age and affects 1/3 of men over 50 years, resulting in filling and emptying symptoms. One of the main limitations of endoscopic techniques for BPH is the occurrence of retrograde ejaculation. The [...] Read more.
Benign prostatic hypertrophy (BPH) is a condition that appears with advancing age and affects 1/3 of men over 50 years, resulting in filling and emptying symptoms. One of the main limitations of endoscopic techniques for BPH is the occurrence of retrograde ejaculation. The purpose of this prospective observational study is to evaluate the efficacy and feasibility of ejaculation-sparing thulium laser enucleation of the prostate (ES-ThuLEP) in the treatment of BPH-related LUTS and the preservation of ejaculation. Sexually active patients with BPH were enrolled and followed up with at 3, 6, and 12 months after surgery. Personal and pharmacological histories were collected, while three standardized questionnaires—the International Index of Erectile Function short form (IIEF-5), the International Consultation on Incontinence Questionnaire for Male Sexual Matters Associated with Lower Urinary Tract Symptoms Module (ICIQ—MLUTSsex), and the International Prostatic Symptom Score (IPSS)—were administered. In addition, all patients underwent uroflowmetry and an assessment of post-void residual volume (PVR). A total of 53 patients were enrolled. A statistically significant improvement in the IPSS score, maximum flow (Qmax), and post-void volume (PVR) at 3 months, 6 months, and 12 months after surgery was found (p < 0.05), while no statistically significant differences were reported between IIEF-5 scores before and after surgery. A total of 48 patients (88.6%) had preserved ejaculation at 3 months, while 92.4% and 94.3% of patients reported preserved ejaculation at 6 and 12 months, respectively. Nevertheless, some degree of hypoposia was referred, at 3, 6, and 12 months, by 43.7%, 30.6%, and 13.2% of patients, respectively. The ES-ThuLEP technique successfully preserved ejaculation in over 90% of patients, representing an ejaculation-sparing alternative in the treatment of BPH. Full article
(This article belongs to the Special Issue Latest Advances on Urological Surgery)
Show Figures

Figure 1

14 pages, 894 KiB  
Article
Purely Off-Clamp Partial Nephrectomy: Robotic Approach Better than Open Using a Pentafecta Outcome with Propensity Score Matching
by Carlo Gandi, Angelo Totaro, Riccardo Bientinesi, Filippo Marino, Francesco Pierconti, Andrea Russo, Marco Racioppi, Pierfrancesco Bassi and Emilio Sacco
J. Clin. Med. 2022, 11(21), 6241; https://doi.org/10.3390/jcm11216241 - 22 Oct 2022
Cited by 8 | Viewed by 1622
Abstract
Partial nephrectomy (PN) is the gold standard treatment for localized renal masses. Robot-assisted PN (RAPN) has overcome laparoscopy’s technical limitations, greatly expanding the indications of minimally invasive PN, which is dominated by renal artery clamping in almost all published series. We compared off-clamp [...] Read more.
Partial nephrectomy (PN) is the gold standard treatment for localized renal masses. Robot-assisted PN (RAPN) has overcome laparoscopy’s technical limitations, greatly expanding the indications of minimally invasive PN, which is dominated by renal artery clamping in almost all published series. We compared off-clamp RAPN (OFFC-RAPN) with the open approach (OFFC-OPN) using propensity score (PS) matching. A favourable pentafecta outcome was defined as a combination of no positive surgical margins (PSM), no complications of Clavien–Dindo (CD) grade ≥ 3, post-operative eGFR loss <10%, length of hospital stay (LOS) ≤ 5 days and estimated blood loss (EBL) < 200 mL. A total of 340 consecutive patients were included. The PS-matched cohort included 142 patients: 71 matched pairs well-balanced for all covariates. The OFFC-RAPN group showed significantly shorter operative time (149.8 vs. 173.9 min, p = 0.003), lower EBL (182.1 vs. 329.3 mL, p = 0.001), and shorter LOS (5.8 vs. 6.9 days, p = 0.02), with a higher proportion of patients with LOS ≤ 5 days (57.7% vs. 23.9%, p < 0.001). No significant differences were found for PSM rate (2.8% vs. 8.4%, p = 0.27), CD > 2 complication rate (4.2% vs. 2.8%, p = 1.00) and mean ± SD eGFR change (−0.06 ± 0.3 vs. −0.8 ± 0.3, p = 0.5). Pentafecta was achieved in 56.3% and 21.1% in the OFFC-RAPN and OFFC-OPN series, respectively (p < 0.0001). On multivariable analysis, surgical approach and BMI proved to be independent predictors of achieving pentafecta. After adjusting for potential treatment selection bias, OFFC-RAPN outperformed OFFC-OPN for important peri-operative outcomes, without compromising oncological and functional safety. Full article
(This article belongs to the Special Issue Latest Advances on Urological Surgery)
Show Figures

Figure 1

16 pages, 1581 KiB  
Article
Comparison of Emergency Room Visits and Rehospitalization for Bleeding Complications following Transurethral Procedures for the Treatment of Benign Prostatic Hyperplasia: A Population-Based Retrospective Cohort Study
by Shih-Liang Chen, Chih-Kai Hsu, Chun-Hsiang Wang, Che-Jui Yang, Ting-Jui Chang, Yu-Hsuan Chuang and Yuan-Tsung Tseng
J. Clin. Med. 2022, 11(19), 5662; https://doi.org/10.3390/jcm11195662 - 26 Sep 2022
Cited by 3 | Viewed by 1837
Abstract
Background: The postoperative bleeding complications associated with laser surgery of the prostate and transurethral resection of the prostate (TURP) were compared. Methods: We used the Taiwan National Health Insurance Research Database to conduct an observational population-based cohort study. All eligible patients who received [...] Read more.
Background: The postoperative bleeding complications associated with laser surgery of the prostate and transurethral resection of the prostate (TURP) were compared. Methods: We used the Taiwan National Health Insurance Research Database to conduct an observational population-based cohort study. All eligible patients who received transurethral procedures between January 2015 and September 2018 were enrolled. Patients who received laser surgery or TURP were matched at a ratio of 1:1 by using propensity score matching, and the association of these procedures with bleeding events was evaluated. Results: A total of 3302 patients who underwent elective transurethral procedures were included. The multivariable Cox regression analysis revealed that diode laser enucleation of the prostate (DiLEP) resulted in significantly higher emergency room risks within 90 days after surgery due to clot retention than the Monopolar transurethral resection of the prostate (M-TURP) (Hazard Ratio: 1.52; 95% Confidence Interval [CI], 1.06–2.16, p = 0.022). Moreover, GreenLight photovaporization of the prostate (PVP) (0.61; 95% CI, 0.38–1.00 p = 0.050) and thulium laser vaporesection of the prostate (ThuVARP) (0.67; 95% CI, 0.47–0.95, p = 0.024) resulted in significantly fewer rehospitalization due to clot retention than did M-TURP. No significant increase in blood clots were observed in patients using comedications and those with different demographic characteristics and comorbidities. Conclusions: Among the investigated six transurethral procedures for Benign prostatic hyperplasia, PVP and ThuVARP were safer than M-TURP because bleeding events and clot retention were less likely to occur, even in patients receiving anticoagulant or antiplatelet therapy. However, DiLEP and holmium laser enucleation of the prostate (HoLEP) did not result in fewer bleeding events than M-TURP. Full article
(This article belongs to the Special Issue Latest Advances on Urological Surgery)
Show Figures

Figure 1

8 pages, 465 KiB  
Article
Evaluation of Functional Outcomes and Quality of Life in Elderly Patients (>75 y.o.) Undergoing Minimally Invasive Radical Cystectomy with Single Stoma Ureterocutaneostomy vs. Bricker Intracorporeal Ileal Conduit Urinary Diversion
by Andrea Fuschi, Yazan Al Salhi, Manfredi Bruno Sequi, Gennaro Velotti, Alessia Martoccia, Paolo Pietro Suraci, Silvio Scalzo, Anastasios Asimakopoulos, Giorgio Bozzini, Alessandro Zucchi, Cosimo De Nunzio, Antonio Carbone and Antonio Luigi Pastore
J. Clin. Med. 2022, 11(1), 136; https://doi.org/10.3390/jcm11010136 - 27 Dec 2021
Cited by 8 | Viewed by 3059
Abstract
Background: Diversion after radical cystectomy (RC) is crucial when considering elderly subjects. Data on the quality of life (QoL) impact with different diversions is scarce. This study aims to compare complications and QoL in patients aged > 75 y.o., who underwent minimally invasive [...] Read more.
Background: Diversion after radical cystectomy (RC) is crucial when considering elderly subjects. Data on the quality of life (QoL) impact with different diversions is scarce. This study aims to compare complications and QoL in patients aged > 75 y.o., who underwent minimally invasive (MI) RC with Bricker intracorporeal urinary derivation and single stoma ureterocutaneostomy. Methods: We conducted a retrospective analysis of elderly patients who underwent MIRC and intracorporeal diversion. The 78 subjects were divided into two groups: group A, ileal conduit, and group B, single stoma ureterocutaneostomy. We evaluated the bowel’s recovery time and complications rate. We investigated QoL 3 and 6 months after surgery using the Stoma-QoL questionnaire. Results: Mean age was 77.2 in group A and 82.4 in group B. The mean ASA score and Charlson Comorbidity index were comparable between the two groups. Rates of complications were 57.6% and 37.4% in groups A and B, respectively. The mean postoperative Stoma-QoL score 3 months after surgery was 52.2 and 52.4 in groups A and B, respectively. At 6 months of follow-up the Stoma QoL mean score was 63.4, showing homogeneity between the groups. Conclusion: MIRC with single stoma ureterocutaneostomy represents an alternative to ileal conduit, with comparable QoL and ostomy management 6 months after surgery, reporting fewer complications. Full article
(This article belongs to the Special Issue Latest Advances on Urological Surgery)
Show Figures

Figure 1

10 pages, 746 KiB  
Article
Benchmarking PASADENA Consensus along the Learning Curve of Robotic Radical Cystectomy with Intracorporeal Neobladder: CUSUM Based Assessment
by Riccardo Lombardo, Riccardo Mastroianni, Gabriele Tuderti, Mariaconsiglia Ferriero, Aldo Brassetti, Umberto Anceschi, Salvatore Guaglianone, Cosimo De Nunzio, Antonio Cicione, Andrea Tubaro, Michele Gallucci and Giuseppe Simone
J. Clin. Med. 2021, 10(24), 5969; https://doi.org/10.3390/jcm10245969 - 19 Dec 2021
Cited by 12 | Viewed by 2451
Abstract
(1) Aim: Robot assisted radical cystectomy (RARC) with intacorporeal neobladder (iN) is a challenging procedure. There is a paucity of reports on RARC-iN, the extracorporeal approach being the most used. The aim of our study was to assess the learning curve of RARC-iN [...] Read more.
(1) Aim: Robot assisted radical cystectomy (RARC) with intacorporeal neobladder (iN) is a challenging procedure. There is a paucity of reports on RARC-iN, the extracorporeal approach being the most used. The aim of our study was to assess the learning curve of RARC-iN and to test its performance in benchmarking Pasadena consensus outcomes. (2) Material and methods: The single-institution learning curve of RARC-iN was retrospectively evaluated. Demographic, clinical and pathologic data of all patients were recorded. Indications to radical cystectomy included muscle invasive bladder cancer (pT ≥ 2) or recurrent high grade non muscle invasive bladder cancer. The cumulative sum (CUSUM) technique, one of the methods developed to monitor the performance and quality of the industrial sector, was adopted by the medical field in the 1970s to analyze learning curves for surgical procedures. The learning curve was evaluated using the following criteria: 1. operative time (OT) <5 h; 2. 24-h Hemoglobin (Hb) drop <2 g/dl; 3. severe complications (according to the Clavien classification system) <30%; 4. positive surgical margins <5%; and 5. complete lymph-node dissection defined as more than 16 nodes. Benchmarking of all five items on quintile analysis was tested, and a failure rate <20% for any outcome was set as threshold. (3) Results: the first 100 consecutive RARC-iN patients were included in the analysis. At CUSUM analysis, RARC required 20 cases to achieve a plateau in terms of operative time (defined as more than 3 consecutive procedures below 300 min). Hemoglobin drop, PSM and number of removed lymph-nodes did not change significantly along the learning curve. Overall, 41% of the patients presented at least one complication. Low-grade and high-grade complication rates were 30% and 17%, respectively. When assessing the benchmarks of all five Pasadena consensus outcomes on quintile analysis, a plateau was achieved after the first 60 cases. (4) Conclusions: RARC-iN is a challenging procedure. The potential impact of the learning curve on significant outcomes, such as high grade complications and positive surgical margins, has played a detrimental effect on its widespread adoption. According to this study, in tertiary referral centers, 60 procedures are sufficient to benchmark all outcomes defined in Pasadena RARC consensus. Full article
(This article belongs to the Special Issue Latest Advances on Urological Surgery)
Show Figures

Figure 1

Other

Jump to: Editorial, Research

13 pages, 837 KiB  
Systematic Review
Learning Curves in Pediatric Robot-Assisted Pyeloplasty: A Systematic Review
by Niklas Pakkasjärvi, Nellai Krishnan, Liisi Ripatti and Sachit Anand
J. Clin. Med. 2022, 11(23), 6935; https://doi.org/10.3390/jcm11236935 - 24 Nov 2022
Cited by 7 | Viewed by 1894
Abstract
Background: Robot-assisted surgery demands a specific skillset of surgical knowledge, skills, and attitudes from the robotic surgeon to function as part of the robotic team and for maximal utility of the assistive surgical robot. Subsequently, the learning process of robot-assisted surgery entails [...] Read more.
Background: Robot-assisted surgery demands a specific skillset of surgical knowledge, skills, and attitudes from the robotic surgeon to function as part of the robotic team and for maximal utility of the assistive surgical robot. Subsequently, the learning process of robot-assisted surgery entails new modes of learning. We sought to systematically summarize the published data on pediatric robot-assisted pyeloplasty (pRALP) to decipher the learning process by analyzing learning curves. Methods: This review followed the PRISMA guidelines. PubMed, EMBASE, Web of Science, and Scopus databases were systematically searched for ‘learning curve’ AND ‘pediatric pyeloplasty’. All studies presenting outcomes of learning curves (LC) in the context of pRALP in patients < 18 years of age were included. Studies comparing LC in pRALP versus open and/or laparoscopic pyeloplasty were also included; however, those solely focusing on LC in non-robotic approaches were excluded. The methodological quality was assessed using the Newcastle and Ottawa scale. Results: Competency was non-uniformly defined in all fifteen studies addressing learning curves in pRALP. pRALP was considered safe at all stages. Proficiency in pRALP was reached after 18 cases, while competency was estimated to demand 31 operated cases with operative duration as outcome variable. Conclusions: Pediatric RALP is safe during the learning process and ‘learning by doing’ improves efficiency. Competencies with broader implications than time must be defined for future studies. Full article
(This article belongs to the Special Issue Latest Advances on Urological Surgery)
Show Figures

Figure 1

Back to TopTop